SPY363.22+5.76 1.61%
DIA300.43+4.54 1.53%
IXIC12,036.79+156.15 1.31%

Aridis Pharmaceuticals Q3 EPS $(0.65) Up From $(0.87) YoY

Aridis Pharmaceuticals (NASDAQ:ARDS) reported quarterly losses of $(0.65) per share. This is a 25.29 percent increase over losses of $(0.87) per share from the same period last year.

· 11/20/2020 16:07
Aridis Pharmaceuticals (NASDAQ:ARDS) reported quarterly losses of $(0.65) per share. This is a 25.29 percent increase over losses of $(0.87) per share from the same period last year.